Gut Microbiota Metabolites As A New Therapeutic Target In Patients With Coronary Artery Disease And Atrial Fibrillation. Journal of Pharmaceutical Negative Results. Published online January 1, 2023:1221-1227. doi:10.47750/pnr.2023.14.02.157